Medco, Caremark Plan National Medicare Part D Bids; No “Fallback” In 2006
Executive Summary
Medco and Caremark are pursuing a low-risk approach to entering the at-risk drug insurance market under Medicare Part D
You may also be interested in...
Caremark “Whistleblower” Suit Alleges Failure To Reimburse Medicaid
A "whistleblower" lawsuit alleging Caremark failed to satisfy reimbursement obligations to Medicaid asserts that the pharmacy benefit manager violated the False Claims Act while operating under a pre-existing corporate integrity agreement
Caremark “Whistleblower” Suit Alleges Failure To Reimburse Medicaid
A "whistleblower" lawsuit alleging Caremark failed to satisfy reimbursement obligations to Medicaid asserts that the pharmacy benefit manager violated the False Claims Act while operating under a pre-existing corporate integrity agreement
Drug Manufacturers Face Public Opinion Challenge In Medicare Rx
Pharmaceutical manufacturers face a significant challenge in countering bad publicity about the Medicare prescription drug program, National Pharmaceutical Council President Karen Williams said at a World Congress Leadership Summit on Medicare May 23 in Washington, D.C